Cargando…
A quantitative classification of OTC medicines regulations in 30 European countries: dispensing restrictions, distribution, pharmacy ownership, and pricing systems
BACKGROUND: This paper reviews the regulations of over-the-counter (OTC) medicines in 30 European countries with the goal of identifying the regulatory trends and clusters as of May 2022. METHODS: To that end, we reviewed the regulation that directly or indirectly might have an impact on OTC medicin...
Autores principales: | , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9887745/ https://www.ncbi.nlm.nih.gov/pubmed/36717949 http://dx.doi.org/10.1186/s40545-023-00522-7 |
_version_ | 1784880398714535936 |
---|---|
author | López Vila, Eduardo Daniel Buts, Caroline Jegers, Marc |
author_facet | López Vila, Eduardo Daniel Buts, Caroline Jegers, Marc |
author_sort | López Vila, Eduardo Daniel |
collection | PubMed |
description | BACKGROUND: This paper reviews the regulations of over-the-counter (OTC) medicines in 30 European countries with the goal of identifying the regulatory trends and clusters as of May 2022. METHODS: To that end, we reviewed the regulation that directly or indirectly might have an impact on OTC medicines. The data were gathered from the national legislation, reports from international organizations, and the existent literature. The 12 regulatory items obtained were classified into four categories: price, pharmacy ownership, distribution modes, and dispensing restrictions. In addition, these items were also employed in the cluster analysis. RESULTS: Pharmacy ownership is mainly private, and in the majority of countries, OTC medicines are not subject to any pricing system. Almost every country studied allows online selling of OTC medicines, and 16 countries allow non-pharmacy retail to sell OTC medicines as well. The dispensing restrictions applicable in pharmacy retail are similar in the countries studied: they rely on the staff, OTC medicines are placed behind the counter and the doses dispensed tend to be restricted. Concerning non-pharmacy retail, additional dispensing restrictions might be imposed, such as the establishment of buyers’ minimum age, the requirement of a pharmacist to supervise the operations, a regulation on the location in the store, and further restrictions on the package sizes, strength, or pharmaceutical form. The cluster analysis resulted in an initial division between countries that widely allow the sale of OTC medicines in non-pharmacy retail and countries, where pharmacy retail has an OTC monopoly. Based on the regulations, 7 subsequent groups were identified evidencing wide regulatory heterogeneity within the countries studied. CONCLUSIONS: Our findings point out that OTC medicines are in general not subject to pricing systems, selling is allowed online, and ownership of pharmacies is mostly private. However, regarding dispensing restrictions, pharmacy chains, and establishment restrictions of pharmacies, we found heterogeneity that is also visible in our cluster analysis, since we identified 7 clusters. SUPPLEMENTARY INFORMATION: The online version contains supplementary material available at 10.1186/s40545-023-00522-7. |
format | Online Article Text |
id | pubmed-9887745 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2023 |
publisher | BioMed Central |
record_format | MEDLINE/PubMed |
spelling | pubmed-98877452023-02-01 A quantitative classification of OTC medicines regulations in 30 European countries: dispensing restrictions, distribution, pharmacy ownership, and pricing systems López Vila, Eduardo Daniel Buts, Caroline Jegers, Marc J Pharm Policy Pract Research BACKGROUND: This paper reviews the regulations of over-the-counter (OTC) medicines in 30 European countries with the goal of identifying the regulatory trends and clusters as of May 2022. METHODS: To that end, we reviewed the regulation that directly or indirectly might have an impact on OTC medicines. The data were gathered from the national legislation, reports from international organizations, and the existent literature. The 12 regulatory items obtained were classified into four categories: price, pharmacy ownership, distribution modes, and dispensing restrictions. In addition, these items were also employed in the cluster analysis. RESULTS: Pharmacy ownership is mainly private, and in the majority of countries, OTC medicines are not subject to any pricing system. Almost every country studied allows online selling of OTC medicines, and 16 countries allow non-pharmacy retail to sell OTC medicines as well. The dispensing restrictions applicable in pharmacy retail are similar in the countries studied: they rely on the staff, OTC medicines are placed behind the counter and the doses dispensed tend to be restricted. Concerning non-pharmacy retail, additional dispensing restrictions might be imposed, such as the establishment of buyers’ minimum age, the requirement of a pharmacist to supervise the operations, a regulation on the location in the store, and further restrictions on the package sizes, strength, or pharmaceutical form. The cluster analysis resulted in an initial division between countries that widely allow the sale of OTC medicines in non-pharmacy retail and countries, where pharmacy retail has an OTC monopoly. Based on the regulations, 7 subsequent groups were identified evidencing wide regulatory heterogeneity within the countries studied. CONCLUSIONS: Our findings point out that OTC medicines are in general not subject to pricing systems, selling is allowed online, and ownership of pharmacies is mostly private. However, regarding dispensing restrictions, pharmacy chains, and establishment restrictions of pharmacies, we found heterogeneity that is also visible in our cluster analysis, since we identified 7 clusters. SUPPLEMENTARY INFORMATION: The online version contains supplementary material available at 10.1186/s40545-023-00522-7. BioMed Central 2023-01-30 /pmc/articles/PMC9887745/ /pubmed/36717949 http://dx.doi.org/10.1186/s40545-023-00522-7 Text en © The Author(s) 2023 https://creativecommons.org/licenses/by/4.0/Open AccessThis article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/ (https://creativecommons.org/licenses/by/4.0/) . The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/ (https://creativecommons.org/publicdomain/zero/1.0/) ) applies to the data made available in this article, unless otherwise stated in a credit line to the data. |
spellingShingle | Research López Vila, Eduardo Daniel Buts, Caroline Jegers, Marc A quantitative classification of OTC medicines regulations in 30 European countries: dispensing restrictions, distribution, pharmacy ownership, and pricing systems |
title | A quantitative classification of OTC medicines regulations in 30 European countries: dispensing restrictions, distribution, pharmacy ownership, and pricing systems |
title_full | A quantitative classification of OTC medicines regulations in 30 European countries: dispensing restrictions, distribution, pharmacy ownership, and pricing systems |
title_fullStr | A quantitative classification of OTC medicines regulations in 30 European countries: dispensing restrictions, distribution, pharmacy ownership, and pricing systems |
title_full_unstemmed | A quantitative classification of OTC medicines regulations in 30 European countries: dispensing restrictions, distribution, pharmacy ownership, and pricing systems |
title_short | A quantitative classification of OTC medicines regulations in 30 European countries: dispensing restrictions, distribution, pharmacy ownership, and pricing systems |
title_sort | quantitative classification of otc medicines regulations in 30 european countries: dispensing restrictions, distribution, pharmacy ownership, and pricing systems |
topic | Research |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9887745/ https://www.ncbi.nlm.nih.gov/pubmed/36717949 http://dx.doi.org/10.1186/s40545-023-00522-7 |
work_keys_str_mv | AT lopezvilaeduardodaniel aquantitativeclassificationofotcmedicinesregulationsin30europeancountriesdispensingrestrictionsdistributionpharmacyownershipandpricingsystems AT butscaroline aquantitativeclassificationofotcmedicinesregulationsin30europeancountriesdispensingrestrictionsdistributionpharmacyownershipandpricingsystems AT jegersmarc aquantitativeclassificationofotcmedicinesregulationsin30europeancountriesdispensingrestrictionsdistributionpharmacyownershipandpricingsystems AT lopezvilaeduardodaniel quantitativeclassificationofotcmedicinesregulationsin30europeancountriesdispensingrestrictionsdistributionpharmacyownershipandpricingsystems AT butscaroline quantitativeclassificationofotcmedicinesregulationsin30europeancountriesdispensingrestrictionsdistributionpharmacyownershipandpricingsystems AT jegersmarc quantitativeclassificationofotcmedicinesregulationsin30europeancountriesdispensingrestrictionsdistributionpharmacyownershipandpricingsystems |